Polar Asset Management Partners Inc. Denali Therapeutics Inc. Transaction History
Polar Asset Management Partners Inc.
- $2.77 Billion
- Q1 2025
A detailed history of Polar Asset Management Partners Inc. transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Polar Asset Management Partners Inc. holds 20,952 shares of DNLI stock, worth $306,737. This represents 0.01% of its overall portfolio holdings.
Number of Shares
20,952
Previous 551,092
96.2%
Holding current value
$306,737
Previous $11.2 Million
97.47%
% of portfolio
0.01%
Previous 0.18%
Shares
4 transactions
Others Institutions Holding DNLI
# of Institutions
234Shares Held
127MCall Options Held
37.3KPut Options Held
7.9K-
Black Rock Inc. New York, NY13.2MShares$193 Million0.01% of portfolio
-
Baillie Gifford & CO12.1MShares$177 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$173 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA11.4MShares$167 Million0.03% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL6.77MShares$99.1 Million0.02% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $1.96B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...